CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 214 enrolled
Drug / intervention
Serum levels of Procalcitonin, C-reactive protein, lactateother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04213040
NCT04213040N/ACompleted

Is Procalcitonin a Valuable Marker for the Identification of Postoperative Complications After Open-heart Surgery With Cardiopulmonary Bypass?

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital·observational·Posted Dec 30, 2019·Updated Feb 13, 2020

In Brief

An observational study evaluating Serum levels of Procalcitonin, C-reactive protein, lactate for Open Heart Surgery and 6 related conditions. Completed, enrolled 214 participants.

Detailed Summary

The aim of this study was to investigate the impact of serum values of procalcitonin (PCT), C-reactive protein (CRP) and lactate to predict postoperative complications in the early postoperative period after open-heart surgery with cardiopulmonary bypass (CPB).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 30, 2019
Enrollment StartJan 1, 2013
Primary CompletionJul 31, 2013
Study CompletionDec 31, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.5 years ago

Interventions

Serum levels of Procalcitonin, C-reactive protein, lactateother

Serum PCT, CRP, and lactate values were collected postoperatively every day starting on postoperative 12 hours, postoperative days 1 through 5. After the operation, all postoperative complications were recorded during the first seven days period. The relations between diagnostic tests and postoperative complications are sought by the use of the statistical analysis methods.